PFE earnings
Catalyst
PFE earnings
PFE earnings — 2026-08-04
Pfizer's second-quarter results beat earnings expectations, helped by strong demand for its blood-thinner portfolio, per Reuters (Aug 4 news pull). The company also outlined an additional $2.5 billion in cost cuts to support margins amid ongoing post-pandemic revenue pressure. Reuters did not disclose specific EPS or revenue figures, so the earnings basis (GAAP vs. non-GAAP) is unstated. Shares added 1.52% on the day, per the daily summary.
Sources
- News pull: latest
- Filed financials: edgar — the quarter ending 2026-06-28 filed revenue $15.03B and GAAP diluted EPS −$0.04; Reuters' "beat" is on the company's adjusted basis, the filing is the GAAP record.
Related
9 events DateTypeEvent
Aug 4 Market BriefThe Hardware Complex Fires First, and the Wall Hits Tonight Aug 5 The PrintsThe Prints Aug 5 Market BriefFear Disarms Into the Week's Biggest Print Wall Aug 8 ScanHealthcare Scan Jul 31 ScanHealthcare Scan Jul 28 ScanHealthcare Scan Aug 14 ScanHealthcare Scan Jul 25 ScanHealthcare Scan Jul 17 ScanHealthcare Scan No direct external sources are attached to this read.